Evaluation of telomerase in non-melanoma skin cancer

  • Authors:
    • L. Boldrini
    • B. Loggini
    • S. Gisfredi
    • Y. Zucconi
    • D. Di Quirico
    • R. Biondi
    • G. Cervadoro
    • P. Barachini
    • F. Basolo
    • R. Pingitore
    • G. Fontanini
  • View Affiliations

  • Published online on: May 1, 2003     https://doi.org/10.3892/ijmm.11.5.607
  • Pages: 607-611
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Telomerase, a ribonucleoprotein, is capable of adding telomeric sequences (TTAGGG hexameric repeats) to the ends of chromosomes and, thereby, halting the erosion of chromosome at each cell division. Whereas most normal somatic cells contain minimal or no detectable telomerase activity, most immortal and tumour cells exhibit significant levels of telomerase activity and show no net loss of telomere length during proliferation. The evaluation of telomerase has been proposed for diagnostic and therapeutic purposes in human cancer. Skin cancer is the most common cancer in humans; the precise molecular events in skin carcinogenesis are numerous and complicated and not yet completely clarified. In this study, we evaluated telomerase in 35 basal cell carcinomas and in 14 squamous cell carcinomas in order to determine if activation of the telomerase enzyme was a pivotal step in the development of skin cancer and whether telomerase activity levels were different between the two histotypes. A higher enzymatic level was shown to be associated with squamous cell carcinomas, while low levels were mainly detected in the basal cell histotype (χ2 test; p=0.02). Telomerase complex activity is dependent on its catalytic subunit, telomerase reverse transcriptase hTERT. By reverse transcription-PCR, using primers within the reverse transcriptase domain of hTERT, we observed a significant correlation between hTERT expression and telomerase activity in our skin tumour samples (p=0.0003). We detected the presence of multiple, alternately spliced transcripts, corresponding to full-length messages as well as spliced messages with critical reverse transcriptase motifs deleted. A higher telomerase messenger level was shown to be associated with squamous cell carcinomas (χ2 test; p<0.0001), as for telomerase activity. Our results provide arguments supporting the role of telomerase in skin cancer and suggest RT-PCR of telomerase RNA as a tool easier and faster than TRAP assay to identify more aggressive malignancies among non-melanoma skin specimens.

Related Articles

Journal Cover

May 2003
Volume 11 Issue 5

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Boldrini L, Loggini B, Gisfredi S, Zucconi Y, Di Quirico D, Biondi R, Cervadoro G, Barachini P, Basolo F, Pingitore R, Pingitore R, et al: Evaluation of telomerase in non-melanoma skin cancer. Int J Mol Med 11: 607-611, 2003
APA
Boldrini, L., Loggini, B., Gisfredi, S., Zucconi, Y., Di Quirico, D., Biondi, R. ... Fontanini, G. (2003). Evaluation of telomerase in non-melanoma skin cancer. International Journal of Molecular Medicine, 11, 607-611. https://doi.org/10.3892/ijmm.11.5.607
MLA
Boldrini, L., Loggini, B., Gisfredi, S., Zucconi, Y., Di Quirico, D., Biondi, R., Cervadoro, G., Barachini, P., Basolo, F., Pingitore, R., Fontanini, G."Evaluation of telomerase in non-melanoma skin cancer". International Journal of Molecular Medicine 11.5 (2003): 607-611.
Chicago
Boldrini, L., Loggini, B., Gisfredi, S., Zucconi, Y., Di Quirico, D., Biondi, R., Cervadoro, G., Barachini, P., Basolo, F., Pingitore, R., Fontanini, G."Evaluation of telomerase in non-melanoma skin cancer". International Journal of Molecular Medicine 11, no. 5 (2003): 607-611. https://doi.org/10.3892/ijmm.11.5.607